Watch: FDA Commissioner on lifting warnings on hormone therapy for menopause

The FDA is removing box warning labels from hormone therapy drugs used for menopause, a significant change after years of such warnings. FDA Commissioner Marty Makary discussed this decision in an interview with NPR, highlighting the agency's reassessment of the risks associated with these therapies. This move is important as it may encourage more women to consider hormone therapy for menopause management, potentially improving their quality of life.